Healthcare Leadership Series: Max Schrecklinger, Head of Corporate Strategy & Development at Boehringer Ingelheim

IESE Healthcare Club welcomes Max Schrecklinger, Head of Corporate Strategy & Development at Boehringer Ingelheim to give a talk about corporate strategy in the healthcare sector and Boehringer Ingelheim

Bio Max Schrecklinger:

Since 2017: Boehringer Ingelheim Head of Corporate Strategy & Development, Ingelheim/Germany
2014-2016: Boehringer Ingelheim CFO mid-sized European countries, Amsterdam/Netherlands
2013: Boehringer Ingelheim CFO Nordics, Stockholm/Sweden
2010-2012: Boehringer Ingelheim Head of Corporate Tax & Financial Logistics, Ingelheim/Germany
2007-2009: Boehringer Ingelheim Head of Group Accounting, Ingelheim/Germany
2006-2007: Boehringer Ingelheim Manager Group Accounting, Ingelheim/Germany
2002-2005: Auditor at PricewaterhouseCoopers, Frankfurt/Germany
2002: Diploma in Business & Administration from the University Mannheim/Germany
2005: Certified German Tax Advisor

Boehringer Ingelheim:

Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention. 

Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and the global number two in the Animal Health pharmaceutical sector. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2017, Boehringer Ingelheim achieved net sales of 18 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17 per cent of net sales. 

As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment. 

Career Development Center | Website | View More Events
Co-hosted with: Healthcare Club